In replay, the intervention of our CEO Eric Halioua and one of our investors Marc Foidart of the Noshaq fund on Monday May 17th at the "Success stories" program dedicated to the Biotechnology on the...

PDC*line Pharma CEO Eric Halioua and COO/CFO Laurent Levy will be present at the Bio€quity Europe 2021 conference Delivered Digitally May 17 - 19, 2021

 ! A company presentation made by our CEO on our...

We are very pleased to announce that our abstract describing our current phase I/II clinical trial objectives and design with our cancer vaccine PDC*lung01 has been accepted for presentation at the...

Eric Halioua, our CEO, will give a company presentation and be part of the Advances in Immuno-Oncology Panel at the SACHS FORUM 14th Annual European Life Sciences CEO Forum. He will also give a...

We are very pleased to announce the publication in Vaccines of a new article describing the capability of our Engineered PDC*line Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen...

We are pleased to announce that our CEO Eric Halioua will present PDC*line Pharma strategy and innovative vaccinal platform on January 21, 2021 at LINK-J's inaugural Advanced Therapy Showcase in Tokyo...

PDC*line Pharma team wishes you and your loved ones a festive & healthy holiday season and a successful 2021!

Have a look at the interview of PDC*line Pharma 's CEO Eric Halioua by Andrew McConaghie a journalist of SCRIP in an on-demand "Fireside Chat" session during the BIOEUROPE FALL 2020. He presents the...

Eric Halioua, President & CEO of PDC*line Pharma will be today, Nov. 2nd 2020, a panelist in a round table on Therapeutic Cancer vaccines and make a company presentation at the Festival of Biologics v...

PDC*line Pharma, a biotech company developing a novel class of potent and off-the-shelf cancer immunotherapies to treat cancer patients, today announced that the Company will give presentations and...